Approval · Notice of Compliance 24472 · 2020
TRURAPI: Notice of Compliance 24472
Issued October 15, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24472
- Date
- October 15, 2020
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- NOVORAPID
Products in this notice
Medicinal ingredients
- INSULIN ASPART 100 UNIT per ML